Oscar Health (OSCR) Cash from Investing Activities (2020 - 2026)

Oscar Health (OSCR) has 7 years of Cash from Investing Activities data on file, last reported at -$590.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 238.78% year-over-year to -$590.3 million; the trailing twelve-month figure through Mar 2026 stood at -$657.1 million (up 47.89% YoY), and the FY2025 full-year result was -$241.1 million, up 82.63% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$590.3 million, down from -$48.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $298.8 million in Q3 2022 and bottomed at -$706.7 million in Q4 2022.
• The 5-year median for Cash from Investing Activities is -$31.4 million (2024), against an average of -$109.9 million.
• Peak annual rise in Cash from Investing Activities reached 2516.48% in 2022, while the deepest fall reached 3462.43% in 2022.
• A 5-year view of Cash from Investing Activities shows it stood at -$706.7 million in 2022, then soared by 124.41% to $172.5 million in 2023, then tumbled by 118.23% to -$31.4 million in 2024, then sank by 54.88% to -$48.7 million in 2025, then slumped by 1111.87% to -$590.3 million in 2026.
• The last three Cash from Investing Activities figures came in at -$590.3 million (Q1 2026), -$48.7 million (Q4 2025), and $150.1 million (Q3 2025), per Business Quant data.

Peer Comparison